Open Access
Open access
volume 16 issue 9 pages 1259

Revolutionizing Medicinal Chemistry: The Application of Artificial Intelligence (AI) in Early Drug Discovery

Publication typeJournal Article
Publication date2023-09-06
scimago Q1
wos Q1
SJR1.019
CiteScore7.7
Impact factor4.8
ISSN14248247
PubMed ID:  37765069
Drug Discovery
Pharmaceutical Science
Molecular Medicine
Abstract

Artificial intelligence (AI) has permeated various sectors, including the pharmaceutical industry and research, where it has been utilized to efficiently identify new chemical entities with desirable properties. The application of AI algorithms to drug discovery presents both remarkable opportunities and challenges. This review article focuses on the transformative role of AI in medicinal chemistry. We delve into the applications of machine learning and deep learning techniques in drug screening and design, discussing their potential to expedite the early drug discovery process. In particular, we provide a comprehensive overview of the use of AI algorithms in predicting protein structures, drug–target interactions, and molecular properties such as drug toxicity. While AI has accelerated the drug discovery process, data quality issues and technological constraints remain challenges. Nonetheless, new relationships and methods have been unveiled, demonstrating AI’s expanding potential in predicting and understanding drug interactions and properties. For its full potential to be realized, interdisciplinary collaboration is essential. This review underscores AI’s growing influence on the future trajectory of medicinal chemistry and stresses the importance of ongoing synergies between computational and domain experts.

Found 
Found 

Top-30

Journals

1
2
3
Pharmaceuticals
3 publications, 2.94%
Briefings in Bioinformatics
2 publications, 1.96%
ACS Infectious Diseases
2 publications, 1.96%
Intelligent Pharmacy
2 publications, 1.96%
Molecules
2 publications, 1.96%
Journal of Molecular Structure
2 publications, 1.96%
Methods in Microbiology
2 publications, 1.96%
International Journal of Pharmaceutics
2 publications, 1.96%
Journal of Chemical Information and Modeling
2 publications, 1.96%
PLoS ONE
2 publications, 1.96%
Advances in Pharmacology
2 publications, 1.96%
Computational Biology and Chemistry
2 publications, 1.96%
Methods in Molecular Biology
2 publications, 1.96%
Receptors
1 publication, 0.98%
Talanta
1 publication, 0.98%
Russian Chemical Reviews
1 publication, 0.98%
Future Journal of Pharmaceutical Sciences
1 publication, 0.98%
Drug Discovery Today
1 publication, 0.98%
Biocatalysis and Agricultural Biotechnology
1 publication, 0.98%
Nano TransMed
1 publication, 0.98%
AAPS PharmSciTech
1 publication, 0.98%
Journal of Drug Targeting
1 publication, 0.98%
Expert Review of Precision Medicine and Drug Development
1 publication, 0.98%
Ageing Research Reviews
1 publication, 0.98%
Current Opinion in Structural Biology
1 publication, 0.98%
Marketing the Green School
1 publication, 0.98%
ACS Chemical Neuroscience
1 publication, 0.98%
European Journal of Pharmacology
1 publication, 0.98%
ACS Omega
1 publication, 0.98%
1
2
3

Publishers

5
10
15
20
25
30
35
Elsevier
32 publications, 31.37%
Springer Nature
13 publications, 12.75%
MDPI
12 publications, 11.76%
American Chemical Society (ACS)
7 publications, 6.86%
Wiley
5 publications, 4.9%
Institute of Electrical and Electronics Engineers (IEEE)
5 publications, 4.9%
IGI Global
4 publications, 3.92%
Taylor & Francis
3 publications, 2.94%
Bentham Science Publishers Ltd.
3 publications, 2.94%
Oxford University Press
2 publications, 1.96%
Public Library of Science (PLoS)
2 publications, 1.96%
Royal Society of Chemistry (RSC)
2 publications, 1.96%
Ovid Technologies (Wolters Kluwer Health)
2 publications, 1.96%
Autonomous Non-profit Organization Editorial Board of the journal Uspekhi Khimii
1 publication, 0.98%
Research Square Platform LLC
1 publication, 0.98%
SAGE
1 publication, 0.98%
JMIR Publications
1 publication, 0.98%
Pleiades Publishing
1 publication, 0.98%
The University of Jordan
1 publication, 0.98%
Georg Thieme Verlag KG
1 publication, 0.98%
Frontiers Media S.A.
1 publication, 0.98%
Cambridge University Press
1 publication, 0.98%
Technosphera JSC
1 publication, 0.98%
5
10
15
20
25
30
35
  • We do not take into account publications without a DOI.
  • Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
103
Share
Cite this
GOST |
Cite this
GOST Copy
Han R. et al. Revolutionizing Medicinal Chemistry: The Application of Artificial Intelligence (AI) in Early Drug Discovery // Pharmaceuticals. 2023. Vol. 16. No. 9. p. 1259.
GOST all authors (up to 50) Copy
Han R., Yoon H., Kim G., Lee H., Lee Y. Revolutionizing Medicinal Chemistry: The Application of Artificial Intelligence (AI) in Early Drug Discovery // Pharmaceuticals. 2023. Vol. 16. No. 9. p. 1259.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.3390/ph16091259
UR - https://doi.org/10.3390/ph16091259
TI - Revolutionizing Medicinal Chemistry: The Application of Artificial Intelligence (AI) in Early Drug Discovery
T2 - Pharmaceuticals
AU - Han, Ri
AU - Yoon, Hongryul
AU - Kim, Gahee
AU - Lee, Hyundo
AU - Lee, Yoonji
PY - 2023
DA - 2023/09/06
PB - MDPI
SP - 1259
IS - 9
VL - 16
PMID - 37765069
SN - 1424-8247
ER -
BibTex |
Cite this
BibTex (up to 50 authors) Copy
@article{2023_Han,
author = {Ri Han and Hongryul Yoon and Gahee Kim and Hyundo Lee and Yoonji Lee},
title = {Revolutionizing Medicinal Chemistry: The Application of Artificial Intelligence (AI) in Early Drug Discovery},
journal = {Pharmaceuticals},
year = {2023},
volume = {16},
publisher = {MDPI},
month = {sep},
url = {https://doi.org/10.3390/ph16091259},
number = {9},
pages = {1259},
doi = {10.3390/ph16091259}
}
MLA
Cite this
MLA Copy
Han, Ri, et al. “Revolutionizing Medicinal Chemistry: The Application of Artificial Intelligence (AI) in Early Drug Discovery.” Pharmaceuticals, vol. 16, no. 9, Sep. 2023, p. 1259. https://doi.org/10.3390/ph16091259.